Literature DB >> 9458874

Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis.

G L Freeman1, J T Colston, M Zabalgoitia, B Chandrasekar.   

Abstract

We assessed two strains of mice [CD-1 and C3H.HeJ (C3H)] with different responses to coxsackievirus B3 (CVB3) infection at 7, 14, and 21 days after inoculation with 10(5) pfu of CVB3. CD-1 mice developed inflammatory lesions at 7 days that nearly recovered by 21 days; C3H mice demonstrated persistence of infiltrates. Although there were differences in the baseline fractional shortening, it was further reduced at 7 and 14 days in both strains. It recovered in CD-1 mice but remained depressed at 21 days in C3H mice. Interleukin-6 and tumor necrosis factor-alpha transcripts were increased in both strains at 7 days. Levels dropped to near control in CD-1 mice at 21 days but remained elevated in C3H mice. Interleukin-1 beta was minimally elevated in CD-1 mice but increased progressively in C3H mice. mRNA for the inducible form of NO synthase (iNOS) was increased at 7 days in the CD-1 mice, returning to baseline by 14 days; it rose progressively in C3H mice, with a fivefold increase at 21 days. We conclude that mice infected with CVB3 show increased expression of proinflammatory cytokines as well as iNOS associated with reduced contractile performance. In more susceptible mice, contractile depression and cytokine and iNOS expression are more pronounced.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458874     DOI: 10.1152/ajpheart.1998.274.1.H249

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

Review 1.  The role of interleukin-1 in the failing heart.

Authors:  C S Long
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

2.  γδ T lymphocytes kill T regulatory cells through CD1d.

Authors:  Sally A Huber
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

3.  The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene.

Authors:  Y Guo; W K Jones; Y T Xuan; X L Tang; W Bao; W J Wu; H Han; V E Laubach; P Ping; Z Yang; Y Qiu; R Bolli
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Cross-regulation of T regulatory-cell response after coxsackievirus B3 infection by NKT and γδ T cells in the mouse.

Authors:  Wei Liu; Mohamad Moussawi; Brian Roberts; Jonathan E Boyson; Sally A Huber
Journal:  Am J Pathol       Date:  2013-06-05       Impact factor: 4.307

5.  NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease.

Authors:  M Hesse; A W Cheever; D Jankovic; T A Wynn
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

6.  IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis.

Authors:  Wei Liu; Oliver Dienz; Brian Roberts; Mohamad Moussawi; Mercedes Rincon; Sally A Huber
Journal:  Exp Mol Pathol       Date:  2012-03-21       Impact factor: 3.362

7.  Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy.

Authors:  B Chandrasekar; P C Melby; D A Troyer; J T Colston; G L Freeman
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

8.  Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Maria E Campian; Hein J Verberne; Maxim Hardziyenka; Elisabeth A A de Groot; Astrid F van Moerkerken; Berthe L F van Eck-Smit; Hanno L Tan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-06       Impact factor: 9.236

9.  Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.

Authors:  Roberta L DeBiasi; Bridget A Robinson; Barbara Sherry; Ron Bouchard; R Dale Brown; Mona Rizeq; Carlin Long; Kenneth L Tyler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  A glyconutritional mixture (Ambrotose®) provides some amelioration to mice with coxsackievirus-induced pancreatitis.

Authors:  C Gauntt; D Busbee; H J Wood; S Reyna; R Barhoumi; R Burghardt; W McAnalley; H R McDaniel
Journal:  Age (Omaha)       Date:  1999-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.